Daniel A. Okin
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
Papers in
-
- COVID-19 Clinical Research Studies 5
- Oncology 5
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Ruslan M. Medzhitov (3 shared papers)Jay M. Edelberg (1 shared paper)Andrew I. Chin (1 shared paper)Takashi Mikawa (1 shared paper)Inga J. Duignan (1 shared paper)Michael C. Bressan (1 shared paper)Carl J. Vaughan (1 shared paper)Bruce B. Lerman (1 shared paper)
- Journals
- CHEST Journal (3 papers)Cell (2 papers)Immunity (2 papers)American Journal of Kidney Diseases (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Daniel A. Okin
21 papers receiving 897 citations
Peers
Comparison fields: 5 of 102
- Infectious Diseases 127
- Aging 10
- Oncology 130
- Immunology 90
- Genetics 36
Countries citing papers authored by Daniel A. Okin
This map shows the geographic impact of Daniel A. Okin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Okin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Okin more than expected).
Fields of papers citing papers by Daniel A. Okin
This network shows the impact of papers produced by Daniel A. Okin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Okin. The network helps show where Daniel A. Okin may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel A. Okin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 317 | |
| 2 | 2020 | 144 | |
| 3 | 2016 | 108 | |
| 4 | 2006 | 59 | |
| 5 | 2003 | 39 | |
| 6 | 2021 | 39 | |
| 7 | 2022 | 36 | |
| 8 | 2021 | 32 | |
| 9 | 2024 | 27 | |
| 10 | 2013 | 26 | |
| 11 | 2020 | 19 | |
| 12 | 2021 | 19 | |
| 13 | 2025 | 19 | |
| 14 | 2023 | 15 | |
| 15 | 2021 | 9 | |
| 16 | 2022 | 8 | |
| 17 | 2023 | 7 | |
| 18 | 2024 | 3 | |
| 19 | 2023 | 1 | |
| 20 | 2024 | 1 |
About Daniel A. Okin
Daniel A. Okin is a scholar working on Infectious Diseases, Oncology, Molecular Biology, Neurology and Pulmonary and Respiratory Medicine, having authored 23 papers that have together received 929 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Inflammasome and immune disorders (2 papers), Long-Term Effects of COVID-19 (2 papers), Gut microbiota and health (2 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers), Respiratory Support and Mechanisms (2 papers) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Infectious Diseases (127 citations), Aging (10 citations), Oncology (130 citations), Immunology (90 citations) and Genetics (36 citations). Daniel A. Okin has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Ruslan M. Medzhitov, Jay M. Edelberg, Andrew I. Chin, Takashi Mikawa, Inga J. Duignan, Michael C. Bressan, Carl J. Vaughan, Bruce B. Lerman, Anita J Huttner and Craig T. Basson. Their work appears in journals such as CHEST Journal, Cell, Immunity, American Journal of Kidney Diseases and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.